Abstract
Background:
The cytokines interleukin 1 (IL-1) and tumor necrosis factor (TNF) are secreted by the different cell populations of the vascular wall and have been suggested to promote atherosclerosis.
Methods and results:
Their respective roles in fatty-streak formation in apolipoprotein E-deficient mice were investigated by use of IL-1 receptor antagonist and TNF binding protein. Estradiol-17beta was used as a positive control. Blocking TNF seemed to be active in female animals but not in males. IL-1 receptor antagonist was as effective as or more effective than estradiol in both sexes.
Conclusions:
IL-1 plays a crucial role in the initial step of the atherosclerotic process in this animal model, and blocking the activity of this cytokine should be considered as a therapeutic possibility.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Apolipoproteins E / deficiency*
-
Arteriosclerosis / etiology*
-
Arteriosclerosis / pathology
-
Carrier Proteins / administration & dosage
-
Carrier Proteins / pharmacology
-
Carrier Proteins / physiology*
-
Estradiol / pharmacology
-
Female
-
Interleukin 1 Receptor Antagonist Protein
-
Lipid Metabolism
-
Male
-
Mice
-
Mice, Inbred C57BL
-
Mice, Knockout
-
Receptors, Tumor Necrosis Factor*
-
Receptors, Tumor Necrosis Factor, Type I
-
Sialoglycoproteins / administration & dosage
-
Sialoglycoproteins / pharmacology
-
Sialoglycoproteins / physiology*
-
Tumor Necrosis Factor Decoy Receptors
Substances
-
Apolipoproteins E
-
Carrier Proteins
-
Il1rn protein, mouse
-
Interleukin 1 Receptor Antagonist Protein
-
Receptors, Tumor Necrosis Factor
-
Receptors, Tumor Necrosis Factor, Type I
-
Sialoglycoproteins
-
Tumor Necrosis Factor Decoy Receptors
-
recombinant human tumor necrosis factor-binding protein-1
-
Estradiol